Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia

Am J Cardiol. 1997 May 1;79(9):1298-301. doi: 10.1016/s0002-9149(97)00109-4.

Abstract

Pravastatin treatment of combined hyperlipidemia lowers low-density lipoprotein effectively; nicotinic acid lowers remnant cholesterol and raises high-density lipoprotein. A combination of these 2 drugs may be indicated for optimal treatment of lipoprotein abnormalities in combined hyperlipidemia.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cross-Over Studies
  • Humans
  • Hyperlipidemias / drug therapy*
  • Middle Aged
  • Niacin / therapeutic use*
  • Pravastatin / therapeutic use*
  • Risk Factors
  • Triglycerides / blood

Substances

  • Anticholesteremic Agents
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Triglycerides
  • Niacin
  • Cholesterol
  • Pravastatin